SiPore15™

The first medical device for the prevention of diabetes

About SiPore15™

SiPore15™ is a breakthrough medical device for the reduction of blood sugar, with a non-invasive mode of action: designed to act locally in the gut without being absorbed by the body, the device offers a superior safety profile.

SiPore15™ is Sigrid Therapeutics’ lead product candidate in clinical development, originating from research at Stockholm University and Uppsala University, Sweden.

Read about our research

Designed for a purpose

SiPore15™ has been developed with optimal safety in mind. The device is orally available as a tasteless and odourless white powder, consisting of precisely engineered micrometre-sized synthetic amorphous silicon dioxide particles with tailored nano-sized porosity. The particles work exclusively in the gut and are not absorbed by the body.

Read about our research

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Sana AljmovicCEO

13

Projects

13

Projects

13

Projects

13

Projects
A Little Of Our Story

Leadership

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. A small river named Duden flows by their place and supplies it with the necessary regelialia.

See Our Story